Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study

BACKGROUND: We have previously reported that expression of the RNA- and DNA-binding protein RBM3 is associated with a good prognosis in breast cancer and ovarian cancer. In this study, the prognostic value of immunohistochemical RBM3 expression was assessed in incident cases of malignant melanoma fr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Jonsson, Liv, Bergman, Julia, Nodin, Björn, Manjer, Jonas, Pontén, Fredrik, Uhlén, Mathias, Jirström, Karin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2011
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3156749/
https://ncbi.nlm.nih.gov/pubmed/21777469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-114
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia